Inventor · disambiguated record
Zheng Wei
Also filed as: WEI ZHENG
23 granted patents·16 pending applications·365 citations·filing 2000–2020
96Inventor score
Top patents by PatentIndex Score
39 records- 0198US7622583B2Heteroaryl sulfonamides and CCR2CHEMOCENTRYX INC·Filed 2006·Granted Nov 24, 2009·106 cites·5 claims
- 0296US6939885B2Aryl sulfonamidesCHEMOCENTRYX·Filed 2003·Granted Sep 6, 2005·87 cites·4 claims
- 0393US7582661B2Aryl sulfonamidesCHEMOCENTRYX INC·Filed 2005·Granted Sep 1, 2009·18 cites·17 claims
- 0492US8093247B2Heteroaryl sulfonamides and CCR2UNGASHE SOLOMON·Filed 2009·Granted Jan 10, 2012·18 cites·15 claims
- 0591US7335653B2Bis-aryl sulfonamidesCHEMOCENTRYX INC·Filed 2007·Granted Feb 26, 2008·9 cites·4 claims
- 0690US6699677B1Tethered ligands and methods of useCHEMOCENTRYX INC·Filed 2000·Granted Mar 2, 2004·31 cites·37 claims
- 0788US7396653B2Cell migration assayCHEMOCENTRYX INC·Filed 2007·Granted Jul 8, 2008·10 cites·22 claims
- 0888US7227035B2Bis-aryl sulfonamidesCHEMOCENTRYX·Filed 2004·Granted Jun 5, 2007·30 cites·18 claims
- 0987US8211896B2Aryl sulfonamidesUNGASHE SOLOMON·Filed 2010·Granted Jul 3, 2012·9 cites·78 claims
- 1083US7420055B2Aryl sulfonamidesCHEMOCENTRYX INC·Filed 2004·Granted Sep 2, 2008·13 cites·7 claims
- 1181US10206912B2Heteroaryl sulfonamides and CCR2/CCR9CHEMOCENTRYX INC·Filed 2016·Granted Feb 19, 2019·2 cites·26 claims
- 1281US7282338B2Cell migration assayCHEMOCENTRYX INC·Filed 2002·Granted Oct 16, 2007·15 cites·16 claims
- 1375US7468253B2Method for multiple chemokine receptor screening for antagonists using RAM assayCHEMOCENTRYX INC·Filed 2003·Granted Dec 23, 2008·12 cites·60 claims
- 1473US11433061B2Heteroaryl sulfonamides and CCR2/CCR9CHEMOCENTRYX INC·Filed 2020·Granted Sep 6, 2022·0 cites·16 claims
- 1570US7442512B2Compositions and methods for detecting and treating diseases and conditions related to chemokine receptorsCHEMOCENTRYX INC·Filed 2002·Granted Oct 28, 2008·5 cites·22 claims
- 1666US10532044B2Heteroaryl sulfonamides and CCR2/CCR9CHEMOCENTRYX INC·Filed 2019·Granted Jan 14, 2020·0 cites·20 claims
- 1766US9890148B2Aryl sulfonamidesCHEMOCENTRYX INC·Filed 2014·Granted Feb 13, 2018·0 cites·11 claims
- 1866US2009270616A1Aryl sulfonamidesCHEMOCENTRYX INC·Filed 2009·Application pending·0 cites
- 1964US10364240B2Aryl sulfonamidesCHEMOCENTRYX INC·Filed 2017·Granted Jul 30, 2019·0 cites·18 claims
- 2064US2009118307A1Aryl SulfonamidesCHEMOCENTRYX INC·Filed 2008·Application pending·0 cites
- 2164US2009163498A1Aryl SulfonamidesCHEMOCENTRYX INC·Filed 2008·Application pending·0 cites
- 2264US2008293717A1Aryl sulfonamidesCHEMOCENTRYX INC·Filed 2008·Application pending·0 cites
- 2362US2013267492A1Aryl sulfonamidesCHEMOCENTRYX INC·Filed 2013·Application pending·0 cites
- 2460US7741519B2Bis-aryl sulfonamidesCHEMOCENTRYX INC·Filed 2008·Granted Jun 22, 2010·0 cites·20 claims
- 2555US2012014997A1Aryl sulfonamidesUNGASHE SOLOMON·Filed 2011·Application pending·0 cites
- 2654US2004167113A1Bis-aryl sulfonamidesFiled 2003·Application pending·0 cites
- 2754US2003215460A1Methods and compositions for inducing an immune responseFiled 2002·Application pending·0 cites
- 2851US2014031348A1Heteroaryl sulfonamides and ccr2/ccr9CHEMOCENTRYX INC·Filed 2013·Application pending·0 cites
- 2950US8642808B2Bis-aryl sulfonamidesUNGASHE SOLOMON·Filed 2011·Granted Feb 4, 2014·0 cites·7 claims
- 3050US2005186556A1Cell migration assayCHEMOCENTRYX·Filed 2005·Application pending·0 cites
- 3149US7413866B2Compositions and methods for detecting and treating diseases and conditions related to chemokine receptorsCHEMOCENTRYX INC·Filed 2003·Granted Aug 19, 2008·0 cites·2 claims
- 3248US2010041896A1Macrolide compound with bis-oxazolyWEI ZHENG·Filed 2008·Application pending·0 cites
- 3348US2010227902A1Bis-aryl sulfonamidesCHEMOCENTRYX INC·Filed 2010·Application pending·0 cites
- 3446US9365511B2Biphenyl-ethyl-pyrrolidine derivatives as histamine H3 receptor modulators for the treatment of cognitive disordersARENA PHARM INC·Filed 2014·Granted Jun 14, 2016·0 cites·28 claims
- 3546US8637043B2Compositions useful as ligands for the formyl peptide receptor like 1 receptor and methods of use thereofSCHALL THOMAS J·Filed 2005·Granted Jan 28, 2014·0 cites·11 claims
- 3646US2007021466A1CCR2 inhibitors and methods of use thereofUNGASHE SOLOMON·Filed 2006·Application pending·0 cites
- 3746US2010234364A1Ccr2 inhibitors and methods of use thereofBASAK ARINDRAJIT·Filed 2007·Application pending·0 cites
- 3845US2006111351A1Aryl sulfonamidesUNGASHE SOLOMON·Filed 2005·Application pending·0 cites
- 3942US2006173019A1Heteroaryl sulfonamides and CCR2UNGASHE SOLOMON·Filed 2006·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Zheng Wei files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →